Nagase Viita Co., Ltd. (Headquarters: Kita-ku, Okayama; Representative Director: Naoki Yasuba), a member of the NAGASE Group, has conducted an awareness survey for 618 women across Japan, ages 30 to 59, with concerns about fatigue and anemia.
This survey revealed that the highest percentage of women concerned with fatigue and anemia was in the 30–34 age group, and that this percentage tended to decline with age. It also showed that many women thought concerns about fatigue and anemia were triggered by childbirth. Furthermore, over 60 percent of women concerned with fatigue and anemia were aware that they were not fundamentally curing fatigue and anemia. This indicated that many women found effectively relieving fatigue and anemia to be difficult. On the other hand, the survey also revealed high expectations for pharmaceutical treatments addressing fatigue and anemia, such as “wanting to fundamentally resolve fatigue and anemia” and “wanting to try available pharmaceuticals that can treat both fatigue and anemia.”
Main Survey Topics
１．The highest percentage of women (ages 30–59) concerned with fatigue and anemia were between 30 and 34 years old.
The highest percentage of women concerned with symptoms of both fatigue and anemia was among women ages 30–34 at 11.4%. Furthermore, that percentage trended downward with age, with women ages 55–59 at 2.2%. Results also showed women “worrying more about fatigue and anemia following childbirth” (75.4%), indicating that many women felt their concerns were triggered by childbirth.
２．The majority of women recognize that fatigue and anemia are not being fundamentally treated.
Over 60 percent of women concerned with fatigue and anemia recognize that fatigue and anemia are not being treated fundamentally, indicating that they think “fatigue and anemia are not being fundamentally treated” (65.9%).
３．High expectations for pharmaceutical treatments addressing both fatigue and anemia
Many responses indicated “wanting to fundamentally resolve fatigue and anemia” (95.5%) as well as “wanting to try available pharmaceuticals that can treat overall fatigue and anemia” (82.4%), also showing high expectations for pharmaceuticals treating fatigue and anemia. |
The survey report is only available in Japanese. Please read it here.
